Literature DB >> 19013529

Elk-1 interacts with neuronal microtubules and relocalizes to the nucleus upon phosphorylation.

Ozlem Demir1, Sirin Korulu, Aysegul Yildiz, Arzu Karabay, Isil Aksan Kurnaz.   

Abstract

ETS domain transcription factor Elk-1 has been primarily studied in the regulation of genes in response to mitogenic stimuli, however the presence of Elk-1 in axonal projections of largely post-mitotic adult hippocampal sections has been reported. This finding has initially led us to a basic question: how is Elk-1 anchored to neuronal projections? To that end, we have investigated the intracellular localization of Elk-1 and its biochemical interactions with neuronal microtubules in model systems. Our results showed co-localization of Elk-1 with microtubules in hippocampal cultures and SH-SY5Y neuroblastoma cell lines, and have further demonstrated that Elk-1 protein can biochemically interact with microtubules in vitro. Analysis of the protein sequence has indicated many putative microtubule binding domains, with the strongest binding prediction in amino acids 314-325, and our results show that Elk-1 can bind to microtubules through most of these regions, but no interaction was observed through the DNA binding domain, where no putative binding motifs were predicted. We further show that upon serum induction, most of the phospho-Elk-1 translocates to the nucleus, which is independent of translation. We propose that Elk-1 is anchored to neuronal microtubules in resting or unstimulated cells, and upon stimulation is phosphorylated, which relocalizes phospho-Elk-1 to the nucleus in neurons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013529     DOI: 10.1016/j.mcn.2008.10.004

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  11 in total

1.  Elk-1 interacts with dynein upon serum stimulation but independent of serine 383 phosphorylation.

Authors:  Ozlem Demir; Oya Ari; Isil Aksan Kurnaz
Journal:  Cell Mol Neurobiol       Date:  2011-09-21       Impact factor: 5.046

2.  A Novel Small Molecule Modulator of Amyloid Pathology.

Authors:  Mark A Lovell; Bert C Lynn; Shuling Fister; Melissa Bradley-Whitman; M Paul Murphy; Tina L Beckett; Christopher M Norris
Journal:  J Alzheimers Dis       Date:  2016-05-04       Impact factor: 4.472

3.  Elk-1 regulates retinal ganglion cell axon regeneration after injury.

Authors:  Takahiko Noro; Sahil H Shah; Yuqin Yin; Riki Kawaguchi; Satoshi Yokota; Kun-Che Chang; Ankush Madaan; Catalina Sun; Giovanni Coppola; Daniel Geschwind; Larry I Benowitz; Jeffrey L Goldberg
Journal:  Sci Rep       Date:  2022-10-19       Impact factor: 4.996

4.  Cell cycle restriction is more important than apoptosis induction for RASSF1A protein tumor suppression.

Authors:  Howard Donninger; Jennifer A Clark; Megan K Monaghan; M Lee Schmidt; Michele Vos; Geoffrey J Clark
Journal:  J Biol Chem       Date:  2014-09-15       Impact factor: 5.157

5.  Elk-1 a transcription factor with multiple facets in the brain.

Authors:  Antoine Besnard; Beatriz Galan-Rodriguez; Peter Vanhoutte; Jocelyne Caboche
Journal:  Front Neurosci       Date:  2011-03-16       Impact factor: 4.677

6.  Serum response factor mediated gene activity in physiological and pathological processes of neuronal motility.

Authors:  Bernd Knöll
Journal:  Front Mol Neurosci       Date:  2011-12-06       Impact factor: 5.639

Review 7.  Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy.

Authors:  Esther Forkosh; Ariel Kenig; Yaron Ilan
Journal:  Pharmacol Res Perspect       Date:  2020-08

8.  Elk1 affects katanin and spastin proteins via differential transcriptional and post-transcriptional regulations.

Authors:  Dolunay Kelle; Koray Kırımtay; Ece Selçuk; Arzu Karabay
Journal:  PLoS One       Date:  2019-02-21       Impact factor: 3.240

9.  Katanin-p80 gene promoter characterization and regulation via Elk1.

Authors:  Ece Selçuk; Koray Kırımtay; Derya Canbaz; Güher Işık Cesur; Sirin Korulu; Arzu Karabay
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

10.  Commentary: Antidepressive effects of targeting ELK-1 signal transduction.

Authors:  Chang-Hoon Cho
Journal:  Front Mol Neurosci       Date:  2018-10-12       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.